Gamechanging blood test predicts breast cancer relapse up to three years before scans
An “ultra-sensitive” blood test can predict which breast cancer survivors will relapse years before scans show evidence of tumours. In the earliest case, the blood test correctly flagged cancer recurrence three years and five months earlier. Experts hope …